Balance Sheet Data
Karyopharm Therapeutics Inc. (KPTI)
$3.32
+0.10 (+3.11%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 328.20 | 261.96 | 249.24 | 228.62 | 277.97 | 1,174.81 | 1,962.21 | 3,277.38 | 5,474.02 | 9,142.95 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | - | 7.86 | 12.88 | 22.50 | 47.09 | 47.12 | 78.70 | 131.45 | 219.56 | 366.71 |
| Account Receivables (%) | ||||||||||
| Inventories | - | 0.35 | 2.64 | 3.45 | 2.59 | 4.32 | 7.21 | 12.05 | 20.12 | 33.61 |
| Inventories (%) | ||||||||||
| Accounts Payable | 4.33 | 0.98 | 4.45 | 14.55 | 10.89 | 18.19 | 30.39 | 50.76 | 84.78 | 141.60 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -2.36 | -0.21 | -0.15 | -5.71 | -0.12 | -5.89 | -9.84 | -16.43 | -27.44 | -45.84 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.